NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

CompletedN/A

Sponsor: Ohio State University

Conditions: HIV-positive Individuals

Interventions: MyTPill, a digital pill

Countries: United States

This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* HIV+, Viral load \>200copies/mL, on single pill containing TDF/FTC, receiving prescription for opioid analgesics

Exclusion Criteria:

* Severe renal or hepatic disease
* Hypersensitivity to silver, magnesium, or zinc following oral use
* Pregnancy
* non-English speaking
* History of Crohn's disease or Ulcerative Colitis
* History of bowel surgery, gastric bypass, or bowel stricture
* History of gastrointestinal malignancy or radiation to the abdomen.

Locations (1)

Miami, Florida, United States